Making Pharmaceutical Markets More Competitive Act

referredUnited States· United States Congress· EN

Introduced

19 May 2017

Last action

26 May 2017 · Referred

Status

Referred to the Subcommittee on Health.

Summary

Making Pharmaceutical Markets More Competitive Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to prioritize the review of generic drug applications and supplements with respect to drugs that are in a shortage or for which there are not more than three approved drugs. The holder of an approved drug application must notify the FDA within 180 days of withdrawing or transferring the application or withdrawing the drug from sale. The FDA must maintain a list of generic drugs with three or fewer holders of approved applications.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

19 May 2017
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
19 May 2017
Introduced
Introduced in House
Source: IntroReferral
19 May 2017
Introduced
Introduced in House
Source: IntroReferral
26 May 2017
Referred
Referred to the Subcommittee on Health.
Source: Committee

Votes

No vote records are attached yet.

Versions

Introduced in House · 19 May 2017 · Download file

Documents

3 official files

Introduced in House (text)

View file Download file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Introduced in House (text)
Introduced in House · EN · 19 May 2017
View Download Open at official source
Introduced in House (PDF)
Introduced in House · EN · 19 May 2017
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 19 May 2017
Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

related to → FDA Reauthorization Act of 2017
related to → Making Pharmaceutical Markets More Competitive Act

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/115th-congress/house-bill/2562
Open data entity: https://api.congress.gov/v3/bill/115/hr/2562
us · 115-hr-2562 · source updated 5 December 2025